NRX Pharmaceuticals (NRXP) Total Non-Current Liabilities (2023 - 2026)
NRX Pharmaceuticals' Total Non-Current Liabilities came in at $15.81 million for Q2 2026, down 34.6% from $24.19 million a year earlier and down 6.7% from the prior quarter.
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
At the end of FY2025, NRX Pharmaceuticals' Total Non-Current Liabilities was $16.59 million, down 21.9% from FY2024.
- Going back by year, Total Non-Current Liabilities was $21.24 million in FY2024 (+11.6%) and $19.03 million in FY2023.
- The Q2 2026 figure represents the lowest quarterly Total Non-Current Liabilities in data going back to Q4 2023.
- Year-over-year, Total Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 8.7% over the last six quarters.
- Business Quant data shows NRXP's Total Non-Current Liabilities at $16.95 million (Q1 2026), $16.59 million (Q4 2025) and $24.89 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | NRX Pharmaceuticals | 126.02 Mn | 77.61 Mn | 426,000.00 | 15.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.81 Mn |
| Mar 31, 2026 | 16.95 Mn |
| Dec 31, 2025 | 16.59 Mn |
| Sep 30, 2025 | 24.89 Mn |
| Jun 30, 2025 | 24.19 Mn |
| Mar 31, 2025 | 22.90 Mn |
| Dec 31, 2024 | 21.24 Mn |
| Sep 30, 2024 | 21.38 Mn |
| Jun 30, 2024 | 23.65 Mn |
| Dec 31, 2023 | 19.03 Mn |
API Access
NRX Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NRXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "NRXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NRXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();